Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Richard Kondo"'
Autor:
Phuong T Nguyen, Hai M Nguyen, Karen M Wagner, Robert G Stewart, Vikrant Singh, Parashar Thapa, Yi-Je Chen, Mark W Lillya, Anh Tuan Ton, Richard Kondo, Andre Ghetti, Michael W Pennington, Bruce Hammock, Theanne N Griffith, Jon T Sack, Heike Wulff, Vladimir Yarov-Yarovoy
Publikováno v:
eLife, Vol 11 (2022)
The voltage-gated sodium NaV1.7 channel plays a key role as a mediator of action potential propagation in C-fiber nociceptors and is an established molecular target for pain therapy. ProTx-II is a potent and moderately selective peptide toxin from ta
Externí odkaz:
https://doaj.org/article/61a7e4bc52cf45b98b9c1e6f378c835a
Autor:
Esther Llagostera, Daniele Catalucci, Luc Marti, Marc Liesa, Marta Camps, Theodore P Ciaraldi, Richard Kondo, Sita Reddy, Wolfgang H Dillmann, Manuel Palacin, Antonio Zorzano, Pilar Ruiz-Lozano, Ramon Gomis, Perla Kaliman
Publikováno v:
PLoS ONE, Vol 2, Iss 11, p e1134 (2007)
Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3'-unstranslated region of the DMPK gene, which encodes a serine/threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associ
Externí odkaz:
https://doaj.org/article/6c86d37245114e479f7100b656b5b6aa
Autor:
Hai M Nguyen, Phuong T Nguyen, Karen M Wagner, Robert G Stewart, Vikrant Singh, Parashar Thapa, Yi-Je Chen, Mark W Lillya, Anh Tuan Ton, Richard Kondo, Andre Ghetti, Michael W Pennington, Bruce Hammock, Theanne N Griffith, Jon T Sack, Heike Wulff, Vladimir Yarov-Yarovoy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33893d32f016b01de0ad9310c1b61a77
https://doi.org/10.7554/elife.81727.sa2
https://doi.org/10.7554/elife.81727.sa2
Autor:
Hai M Nguyen, Phuong T Nguyen, Karen M Wagner, Robert G Stewart, Vikrant Singh, Parashar Thapa, Yi-Je Chen, Mark W Lillya, Anh Tuan Ton, Richard Kondo, Andre Ghetti, Michael W Pennington, Bruce Hammock, Theanne N Griffith, Jon T Sack, Heike Wulff, Vladimir Yarov-Yarovoy
The voltage-gated sodium NaV1.7 channel plays a key role as a mediator of action potential propagation in C-fiber nociceptors and is an established molecular target for pain therapy. ProTx-II is a potent and moderately selective peptide toxin from ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0988b85ef375b455a45538fdc58e6c47
https://escholarship.org/uc/item/35r029z1
https://escholarship.org/uc/item/35r029z1
Autor:
Phuong T. Nguyen, Hai M. Nguyen, Karen M. Wagner, Robert G. Stewart, Vikrant Singh, Parashar Thapa, Yi-Je Chen, Mark W. Lillya, Anh Tuan Ton, Richard Kondo, Andre Ghetti, Michael W. Pennington, Bruce Hammock, Theanne N. Griffith, Jon T. Sack, Heike Wulff, Vladimir Yarov-Yarovoy
The voltage-gated sodium NaV1.7 channel plays a key role as a mediator of action potential propagation in C-fiber nociceptors and is an established molecular target for pain therapy. ProTx-II is a potent and moderately selective peptide toxin from ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2d947d4b583c02645779462fd248962
https://doi.org/10.1101/2022.07.21.500925
https://doi.org/10.1101/2022.07.21.500925
Autor:
Mohammad, Pashmforoush, Jonathan T, Lu, Hanying, Chen, Tara St, Amand, Richard, Kondo, Sylvain, Pradervand, Sylvia M, Evans, Bob, Clark, James R, Feramisco, Wayne, Giles, Siew Yen, Ho, D Woodrow, Benson, Michael, Silberbach, Weinian, Shou, Kenneth R, Chien
Publikováno v:
Cell. 117(3)
Human mutations in Nkx2-5 lead to progressive cardiomyopathy and conduction defects via unknown mechanisms. To define these pathways, we generated mice with a ventricular-restricted knockout of Nkx2-5, which display no structural defects but have pro
Publikováno v:
Biophysical Journal. 106:764a
The U.S. Food and Drug Administration (FDA) guidelines S7B mandate the measurement of inhibition of the human ether-a-go-go-related (hERG) ion channel by new drug candidates as it has been found that drug inhibition of the hERG channel can be associa
Examines the market-entry strategy of a medical device company.